Want to see AU:MPL full AI Analyst Report?
MPL Stock Chart & Stats
AU$5.12
AU$0.02(0.39%)
At close: 4:00 PM EDT
AU$5.12
AU$0.02(0.39%)
Day’s Range― - ―
52-Week RangeAU$4.06 - AU$5.30
Previous CloseN/A
Volume3.75M
Average Volume (3M)5.96M
Market Cap
AU$14.24B
Enterprise ValueAU$13.46K
Total Cash (Recent Filing)AU$453.30M
Total Debt (Recent Filing)AU$481.30M
Price to Earnings (P/E)30.8
Beta0.21
Next Earnings
Aug 20, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend Yield3.51%
Share Statistics
EPS (TTM)0.17
Shares Outstanding2,754,003,200
10 Day Avg. Volume5,399,409
30 Day Avg. Volume5,964,521
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)5.95
Price to Sales (P/S)1.63
P/FCF Ratio37.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$5.14Price Target Upside0.39% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.26
Revenue Forecast (FY)AU$9.68B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet & Strong ROELow leverage and consistently strong ~20%+ ROE provide durable financial flexibility. This conservatism supports dividend policy, capacity to fund M&A or raise Tier‑2 debt if needed, and helps absorb underwriting or investment shocks without eroding core capital over the medium term.
High-growth, Higher-margin Medibank Health SegmentRapid revenue and profit growth in Medibank Health diversifies earnings away from pure insurance underwriting into higher‑margin services. Sustained double-digit growth and improved margins provide a structural profit lever, enhancing group operating profit resilience and offering cross-sell and retention benefits over multiple years.
Strategic Primary Care M&A Expands CapabilitiesAdding a large primary care network accelerates vertical integration and recurring service revenue, enabling care coordination, cost management and deeper customer relationships. This scale supports long-term Medibank Health earnings growth targets and creates structural competitive differentiation versus insurers without clinical assets.
Bears Say
Volatile Cash GenerationMaterial year-to-year swings in free cash flow reduce confidence in internal funding for reinvestment, M&A and dividends. Even with decent cash conversion versus net income, a large FCF decline weakens short-to-medium term liquidity planning and raises reliance on capital markets or retained capital for growth initiatives.
Revenue Mix Shifting To Lower‑tier ProductsA sustained shift toward lower‑tier covers reduces revenue per policy and compresses underwriting margins long term. If consumer mix and aggregator-driven switching persist, management may need deeper pricing or product redesign, which can be slow and politically sensitive in health insurance, pressuring sustainable margin expansion.
Claims Inflation And Negative Hospital UtilizationRising claims costs and shifting utilization patterns increase underwriting volatility and squeeze margins. Negative hospital utilization (partly unwinding COVID tailwinds) and higher extras inflation create ongoing cost pressure that may require higher premiums or benefit design changes, both of which risk customer churn and long-term profitability.
Medibank Private News
MPL FAQ
What was Medibank Private Ltd.’s price range in the past 12 months?
Medibank Private Ltd. lowest share price was AU$4.06 and its highest was AU$5.30 in the past 12 months.
What is Medibank Private Ltd.’s market cap?
Medibank Private Ltd.’s market cap is AU$14.24B.
When is Medibank Private Ltd.’s upcoming earnings report date?
Medibank Private Ltd.’s upcoming earnings report date is Aug 20, 2026 which is in 15 days.
How were Medibank Private Ltd.’s earnings last quarter?
Medibank Private Ltd. released its earnings results on Feb 18, 2026. The company reported AU$0.108 earnings per share for the quarter, missing the consensus estimate of AU$0.11 by -AU$0.002.
Is Medibank Private Ltd. overvalued?
According to Wall Street analysts Medibank Private Ltd.’s price is currently Undervalued.
Does Medibank Private Ltd. pay dividends?
Medibank Private Ltd. pays a Semiannually dividend of AU$0.083 which represents an annual dividend yield of 3.51%. See more information on Medibank Private Ltd. dividends here
What is Medibank Private Ltd.’s EPS estimate?
Medibank Private Ltd.’s EPS estimate is 0.12.
How many shares outstanding does Medibank Private Ltd. have?
Medibank Private Ltd. has 2,754,003,200 shares outstanding.
What happened to Medibank Private Ltd.’s price movement after its last earnings report?
Medibank Private Ltd. reported an EPS of AU$0.108 in its last earnings report, missing expectations of AU$0.11. Following the earnings report the stock price went down -5.638%.
Which hedge fund is a major shareholder of Medibank Private Ltd.?
Currently, no hedge funds are holding shares in AU:MPL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medibank Private Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$5.14 (0.39% Upside)
AU$5.14 (0.39% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.92%
12-Months-Change
Fundamentals
Return on Equity
3.51%
Trailing 12-Months
Asset Growth
9.08%
Trailing 12-Months
Company Description
Medibank Private Ltd.
Medibank Private Limited (MPL.AX) is an Australian firm offering private health insurance alongside a variety of health services. The company operates through two primary divisions. Its Health Insurance division provides a comprehensive suite of private health insurance policies, encompassing coverage for hospital treatments and supplementary benefits for services like dental, optical, and physiotherapy. This division also caters to international visitors and students with specific insurance products, all underwritten by the Medibank and ahm brands. The Medibank Health division delivers health management programs, in-home care solutions, and telehealth services, primarily serving governmental and corporate clients. Furthermore, this segment handles the distribution of travel, life, and pet insurance products. Established in 1976, Medibank Private Limited is headquartered in Docklands, Australia.
MPL Stock 12 Month Forecast
Average Price Target
AU$5.14
▲(0.39% Upside)